Renuka Iyer

7.3k total citations
178 papers, 3.0k citations indexed

About

Renuka Iyer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Renuka Iyer has authored 178 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Oncology, 64 papers in Pulmonary and Respiratory Medicine and 45 papers in Surgery. Recurrent topics in Renuka Iyer's work include Hepatocellular Carcinoma Treatment and Prognosis (43 papers), Pancreatic and Hepatic Oncology Research (36 papers) and Colorectal Cancer Treatments and Studies (31 papers). Renuka Iyer is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (43 papers), Pancreatic and Hepatic Oncology Research (36 papers) and Colorectal Cancer Treatments and Studies (31 papers). Renuka Iyer collaborates with scholars based in United States, United Kingdom and Saudi Arabia. Renuka Iyer's co-authors include Yasmin Thanavala, Amit A. Lugade, Suresh Kalathil, Austin Miller, Boris W. Kuvshinoff, Milind Javle, John F. Gibbs, Gerald J. Fetterly, Alan D. Hutson and Charles LeVea and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Renuka Iyer

172 papers receiving 3.0k citations

Peers

Countries citing papers authored by Renuka Iyer

Since Specialization

Citations

This map shows the geographic impact of Renuka Iyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renuka Iyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renuka Iyer more than expected).

Fields of papers citing papers by Renuka Iyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renuka Iyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renuka Iyer. The network helps show where Renuka Iyer may publish in the future.

Co-authorship network of co-authors of Renuka Iyer

This figure shows the co-authorship network connecting the top 25 collaborators of Renuka Iyer. A scholar is included among the top collaborators of Renuka Iyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renuka Iyer. Renuka Iyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States 2025 ·Journal of Hepatocellular Carcinoma ·Richard Finn, Renuka Iyer, (unknown), Neehar D. Parikh, Roniel Cabrera, (unknown), Ahmed O. Kaseb	0
2	Real-world assessment of MDM2 amplification and survival among patients with advanced or metastatic biliary tract cancer in the United States. 2025 ·Journal of Clinical Oncology ·Renuka Iyer, Kathryn Evans, Alyssa Klein, (unknown), Stephen A. Stanhope, Beth Nordstrom, Vaibhav Sahai	1
3	Tumor microbiome differences in early-onset versus average-onset pancreatic adenocarcinoma. 2024 ·Journal of Clinical Oncology ·Thejus Jayakrishnan, Naseer Sangwan, (unknown), Suneel D. Kamath, M. Patel, Daniel Joyce, Matthew Walsh, Róbert Simon, (unknown), Renuka Iyer, Christos Fountzilas, Alok A. Khorana	1
4	A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without addition of cobimetinib in previously treated unresectable biliary tract cancer. 2024 ·Journal of Clinical Oncology ·Thatcher Heumann, Mark Yarchoan, (unknown), Jiayun Lu, Daneng Li, Paul R. Kunk, Renuka Iyer, Farshid Dayyani, Lionel Aurelien Kankeu Fonkoua, (unknown), Olumide B. Gbolahan, Milind Javle, S. Lindsey Davis, Vaia Florou, James R. Wright, Elad Sharon, Hao Wang, Gregory B. Lesinski, Nilofer S. Azad	3
5	EMERALD-Y90: A Phase 2 Study to Evaluate Transarterial Radioembolization Followed by Durvalumab and Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma Eligible for Embolization 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Renuka Iyer, Anne M. Noonan, Benjamin Spieler, Sarah B. White, Laura Kulik, D. G. Underwood, (unknown), (unknown), G. Barrie Wetherill, (unknown)	4
6	Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer 2023 ·Journal for ImmunoTherapy of Cancer ·Ronan J. Kelly, Katherine M. Bever, Joseph Chao, Kristen K. Ciombor, Cathy Eng, Marwan Fakih, Lipika Goyal, Joleen M. Hubbard, Renuka Iyer, Holly Kemberling, Smitha Krishnamurthi, Geoffrey Y. Ku, (unknown), Van K. Morris, Andrew Scott Paulson, (unknown), Manish A. Shah, Dung T. Le	14
7	Final results of a phase 1b/2 study of tivozanib in combination with durvalumab in patients with advanced hepatocellular carcinoma in both previously untreated patients and patients progressing on atezolizumab and bevacizumab. 2023 ·Journal of Clinical Oncology ·Daneng Li, Farshid Dayyani, Devalingam Mahalingam, Julie Rowe, Thomas A. Abrams, Vijay Kasturi, Renuka Iyer	2
8	Health-Related Quality of Life (HRQoL) in Neuroendocrine Tumors: A Systematic Review 2022 ·Cancers ·Rohit Gosain, (unknown), Arya Mariam Roy, Jonathan Strosberg, Kathryn Glaser, Renuka Iyer	13
9	Imaging of Tumor-Associated Vascular Prostate-Specific Membrane Antigen in Woodchuck Model of Hepatocellular Carcinoma 2022 ·SHILAP Revista de lepidopterología ·(unknown), Yifan Zhang, (unknown), Arun Sasikumar, Amad Awadallah, Jonathan Kenyon, Wuxian Shi, (unknown), Steve S. Huang, Sandra Sexton, Renuka Iyer, Wei Xin, Norbert Avril, E. Ricky Chan, Zhenghong Lee	2
10	Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates 2019 ·Molecular Cancer Therapeutics ·Usha Malhotra, Sarbajit Mukherjee, Christos Fountzilas, Patrick M. Boland, Austin Miller, Santosh K. Patnaik, Kristopher Attwood, Sai Yendamuri, Araba A. Adjei, Eric Kannisto, Mateusz Opyrchal, Peter Bushunow, Peter Loud, Renuka Iyer, Nikhil I. Khushalani	5
11	Multidisciplinary Management of Patients with Unresectable Hepatocellular Carcinoma: A Critical Appraisal of Current Evidence 2019 ·PMC ·Pierre M. Gholam, Renuka Iyer, Matthew S. Johnson	3
12	Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial 2017 ·Thrombosis Research ·Alok A. Khorana, Charles W. Francis, Nicole M. Kuderer, Marc Carrier, Thomas L. Ortel, Ted Wun, Deborah J. Rubens, Susan K. Hobbs, Renuka Iyer, Derick R. Peterson, Andrea Baran, Katherine Kaproth-Joslin, Gary H. Lyman	96
13	Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors 2016 ·Current Oncology Reports ·Venkata K. Pokuri, (unknown), Renuka Iyer	30
14	Molecular Targets in Biliary Carcinogenesis and Implications for Therapy 2015 ·The Oncologist ·Tolutope Oyasiji, Jianliang Zhang, Boris W. Kuvshinoff, Renuka Iyer, Steven N. Hochwald	12
15	Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality 2013 ·Cancer Research ·Suresh Kalathil, Amit A. Lugade, Austin Miller, Renuka Iyer, Yasmin Thanavala	232
16	Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers 2013 ·Thrombosis Research ·(unknown), Alok A. Khorana, Alan D. Hutson, Jianguo Wang, Nigel S. Key, Nigel Mackman, Renuka Iyer	107
17	Occult Primary 2011 ·Journal of the National Comprehensive Cancer Network ·David S. Ettinger, Mark Agulnik, Justin Cates, Mihaela Cristea, Crystal S. Denlinger, Keith D. Eaton, P. Fidias, David S. Gierada, Jon P. Gockerman, Charles R. Handorf, Renuka Iyer, Renato Lenzi, John E. Phay, Asif Rashid, Leonard B. Saltz, Lawrence N. Shulman, Jeffrey B. Smerage, Gauri R. Varadhachary, Jonathan S. Zager, Weining Zhen	35
18	Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report 2008 ·Cancer Chemotherapy and Pharmacology ·(unknown), (unknown), Joanne Becker, (unknown), James W. Lohr, George Deeb, Renuka Iyer	39
19	Akt expression may predict favorable prognosis in cholangiocarcinoma 2006 ·Journal of Gastroenterology and Hepatology ·Milind Javle, Jihnhee Yu, Thaer Khoury, (unknown), Renuka Iyer, Jason M. Foster, Boris W. Kuvshinoff, John F. Gibbs, Joseph Geradts, Jennifer D. Black, Michael G. Brattain	41
20	Chemoradiation is a tolerable therapy for older adults with esophageal cancer. 2005 ·PubMed ·Sujatha Nallapareddy, Gregory E. Wilding, Gary Yang, Renuka Iyer, Milind Javle	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact